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Abstract 
 
Rhabdomyosarcomas (RMS) are thought to arise from pluripotent muscle cell precursors intended to 
form the bodys future striated muscle. Due to the wide distribution of striated muscle across the body these 
tumors may appear anywhere and cause symptoms accordingly. Presenting symptoms are highly variable and 
based on the tumor size and location making clinical diagnosis difficult. The diagnosis of RMS is based on 
histological examination; however they express varying cytologic pictures representing the different stages of 
rhabdomyoblasts and their development into skeletal muscle presenting pictures from highly to poorly 
differentiated neoplasms. Therefore their histological diagnosis also requires the use of specialized stains and 
complex staining procedures which may not be available at peripheral centers. Here we would like to present a 
highly aggressive embryonal rhabdomyosarcoma of the maxilla, presenting as a schwanoma on initial 
histopathology. 
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1. Introduction 
 
Rhabdomyosarcomas (RMS) are thought to arise from pluripotent muscle cell precursors 
called rhabdomyoblasts which are intended to form the bodys future striated muscle [1]. Due to the 
wide distribution of striated muscle across the body, these tumors may appear anywhere across the 
body and cause symptoms accordingly; however due to some unknown mechanism the head and neck 
area is the most frequently involved site. Based on their histological features they may be classified as 
embryonal, alveolar, botryoid or spindle cell rhabdomyosarcomas. Around 250 cases of 
rhabdomyosarcoma are expected in the United States each year, with the embryonal subtype 
accounting for about 60% of them [1]. The five year survival for localized rhabdomyosarcoma ranges 
between 73-80% [2-3]. Here we would like to present a highly aggressive embryonal 
rhabdomyosarcoma of the maxilla, presenting as a schwanoma on initial histopathology. 
 
2. Case report 
 
A 12-year old male presented to our emergency room with complaints of a bleeding mass on 
the left cheek. He gave a history of a similar non tender mass at the same location not associated with 
any bleeding or discharge about 2 years ago which persisted for 18 months and regressed 
spontaneously. The mass reappeared 2 months ago upon which he sought medical attention in his 
hometown. The mass was excised and histopathological analysis showed a schwanoma. The mass 
reappeared one week later associated with on and off bleeding and he decided to visit our emergency 
room. 
 
On examination a left buccogingival lesion with an oozing point was noted, keeping the 
previous histopathological diagnosis in mind, recurrence or residual disease from the previously 
excised schwanoma was considered and he was planned for surgery. 
 
The lesion was excised using a sublabial incision to access the anterior wall of maxilla as 
described by Caldwell & Luc [4] and specimen was sent for histopathological examination. His post 
operative recovery was uneventful, and he was discharged awaiting final histopathology report. 
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Following his discharge the final histopathology report showed embryonal rhabdomyosarcoma (Figure 
1) and the patient was planned for further debridement; however he presented to the emergency room 
with a reappearance of the mass associated with bleeding on touch and the procedure was expedited.  
 
The lesion was soft to touch extending from the lip to the inner aspect of the buccal mucosa 
(Figure 2). CT scan showed a large encapsulated lesion in the left maxillary sinus, eroding the medial 
and anterolateral maxillary walls and involving the buccal mucosa, measuring about 5.6x3.6x5.7 cm. 
Significant destruction of the left supra alveolar arch was also noted (Figure 3). 
 
The tumor was surgically excised using a Weber Ferguson approach where the incision is 
made from the ipsilateral nasal vestibule laterally to the base of the nasal columella and extended 
transversely to the midline of the upper lip followed by a horizontal gingivo-buccal incision [4]. He is 
planned for further oncological management.   
 
3. Discussion 
 
Rhabdomyosarcoma (RMS) accounts for around 3.5% of all malignancies in children, with 5-
year survival rates of 73%, according to the Intergroup Rhabdomyosarcoma Study (IRS)-IV. 
Presenting symptoms are highly variable and based on the tumor size and location making clinical 
diagnosis difficult [5]. 
 
 
 
Figure 1. (A) H & E staining of the excised tissue at 20x showing embryonal rhabdomyosarcoma with sheets 
of moderate to poorly differentaited round cells with eosinophilic cytoplam and eccentric, small nuclei, (B) 
shows desmin positivity in these cells. 
 
 
 
Figure 2. The lesion extending from the patients lip to the inner aspect of his buccal mucosa. 
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The diagnosis of RMS is based on histological examination; however they express varying 
cytologic pictures representing the different stages of rhabdomyoblasts and their development into 
skeletal muscle presenting pictures from highly to poorly differentiated neoplasms. RMS may however 
present without any signs of myogenic differentiation on routine staining procedures; requiring the use 
of specialized stains and complex staining procedures, for their histological diagnosis, which may not 
be available at peripheral centers [6], leading to an incorrect histological classification as may have 
been the case with our patient. Due to the rarity of this condition, RMS may be missed out even at 
major centers as this may not be considered among the differentials, in our country cases of RMS are 
even rarer on retrospective review of our records we found only 3 cases of embryonal RMS of the head 
and neck in the last five years. 
 
The aim of treatment in RMS is local control with prevention of systemic metastasis by 
aggressive surgery with associated chemo and radiotherapy [7]; however the treatment for a 
schwanomma in a similar setting may not be as aggressive due to the lower chances of residual and 
recurring disease indicating that differentiation between the two prior to excision is of vital importance. 
Studies have reported an increased risk of embryonal RMS with high birth weight and increased 
gestational size suggesting that accelerated in utero growth may be associated with an increased risk for 
developing embryonal RMS; however the study failed to find such a correlation with other subtypes of 
RMS [8].  
 
Although the prognosis of Embryonal RMS has been shown to be better than other forms of 
RMS it shows a frequent loss of the 11p15.5 allele, which has been suggested to possess tumor 
suppressive activity [9]. Another study comparing the chromosomal imbalances between different 
subtypes of RMS found frequent gains on 7p, 9q, 2p, 18q, 1p and 8q; losses on 11p in cases of 
embryonal RMS [10]. 
 
Autocrine signalling via vascular endothelial growth factor (VEGF) has also been implicated 
in the growth of the tumor, with increases in cell proliferation demonstrated on administration of 
exogenous VEGF. All-trans-retinoic acid has been shown to decrease VEGF secretion, leading to a 
decrease in cell proliferation in RMS [11]. Another study found that genistein arrested the cell-cycle at 
different checkpoints in RMS cells [12]. 
 
4. Conclusions 
 
RMS can be very aggressive and extensive surgical debridement with chemo and radio 
therapy is recommended with close follow up over an extended time period as recurring diseases have 
been reported 20 years after initial multi modality treatment [13]. 
 
The authors recommend that even though a rarity in our population, RMS be kept in mind as a 
differential for pediatric soft tissue malignancies.  
 
 
 
 
 
Figure 3. Axial and coronal CT scans showing the size of the lesion. 
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